Kamiita-cho, Japan

Katsura Tottori

USPTO Granted Patents = 14 



Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 88(Granted Patents)


Location History:

  • Tokushima, JP (1996)
  • Tokushima-ken, JP (1996 - 1997)
  • Kamiita-cho, JP (2006 - 2015)
  • Kamita-Cho, JP (2015)
  • Kamiita, JP (2016)

Company Filing History:


Years Active: 1996-2016

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Innovations of Katsura Tottori

Introduction

Katsura Tottori is a notable inventor based in Kamiita-cho, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of central nervous system disorders. With a total of 14 patents to his name, Tottori's work has had a profound impact on medical science.

Latest Patents

Among his latest patents, Tottori has developed a method for treating patients suffering from disorders associated with the 5-HT receptor subtype. This method involves the use of a carbostyril derivative or a salt thereof, represented by a specific formula. Another significant patent focuses on treating cognitive impairments and schizophrenias, utilizing a similar active ingredient to address central nervous system disorders.

Career Highlights

Katsura Tottori is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to innovate and contribute to the field of medicine. His work is characterized by a commitment to improving patient outcomes through advanced therapeutic methods.

Collaborations

Tottori has collaborated with notable colleagues, including Tetsuro Kikuchi and Tsuyoshi Hirose, who have contributed to his research and development efforts.

Conclusion

Katsura Tottori's innovative work in the pharmaceutical industry exemplifies the importance of research and development in treating complex medical conditions. His contributions continue to pave the way for advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…